Aruna Poduri1, Debra L Rateri1, Deborah A Howatt1, Anju Balakrishnan1, Jessica J Moorleghen1, Lisa A Cassis1, Alan Daugherty2. 1. From the Saha Cardiovascular Research Center (A.P., D.L.R., D.A.H., A.B., J.J.M., A.D.) and Department of Molecular and Biomedical Pharmacology (L.A.C.), University of Kentucky, Lexington. 2. From the Saha Cardiovascular Research Center (A.P., D.L.R., D.A.H., A.B., J.J.M., A.D.) and Department of Molecular and Biomedical Pharmacology (L.A.C.), University of Kentucky, Lexington. Alan.Daugherty@uky.edu.
Abstract
OBJECTIVE: Angiotensin II (Ang II) infusion causes aortic medial thickening via stimulation of angiotensin II type 1a (AT1a) receptors. The purpose of this study was to determine the cellular loci of AT1a receptors that mediate this Ang II-induced aortic pathology. APPROACH AND RESULTS: Saline or Ang II was infused into AT1a receptor floxed mice expressing Cre under control of cell-specific promoters. Initially, AT1a receptors were depleted in aortic smooth muscle cell and endothelium by expressing Cre under control of SM22 and Tie2 promoters, respectively. Deletion of AT1a receptors in either cell type had no effect on Ang II-induced medial thickening. To determine whether this effect was related to neural stimulation, AT1a receptors were depleted using an enolase 2-driven Cre. Depletion of AT1a receptors in neural cells attenuated Ang II-induced medial thickening of the ascending, but not descending aorta. Lineage tracking studies, using ROSA26-LacZ, demonstrated that enolase 2 was also expressed in adventitial cells adjacent to the region of attenuated thickening. To determine whether adventitial fibroblasts contributed to this attenuation, AT1a receptors in fibroblasts were depleted using S100A4 driven Cre. Similar to enolase 2-Cre, Ang II-induced medial thickening was attenuated in the ascending, but not the descending aorta. Lineage tracking demonstrated an increase of S100A4-LacZ positive cells in the media of the ascending region during Ang II infusion. CONCLUSIONS: AT1a receptor depletion in fibroblasts attenuates Ang II-induced medial hyperplasia in the ascending aorta.
OBJECTIVE:Angiotensin II (Ang II) infusion causes aortic medial thickening via stimulation of angiotensin II type 1a (AT1a) receptors. The purpose of this study was to determine the cellular loci of AT1a receptors that mediate this Ang II-induced aortic pathology. APPROACH AND RESULTS:Saline or Ang II was infused into AT1a receptor floxed mice expressing Cre under control of cell-specific promoters. Initially, AT1a receptors were depleted in aortic smooth muscle cell and endothelium by expressing Cre under control of SM22 and Tie2 promoters, respectively. Deletion of AT1a receptors in either cell type had no effect on Ang II-induced medial thickening. To determine whether this effect was related to neural stimulation, AT1a receptors were depleted using an enolase 2-driven Cre. Depletion of AT1a receptors in neural cells attenuated Ang II-induced medial thickening of the ascending, but not descending aorta. Lineage tracking studies, using ROSA26-LacZ, demonstrated that enolase 2 was also expressed in adventitial cells adjacent to the region of attenuated thickening. To determine whether adventitial fibroblasts contributed to this attenuation, AT1a receptors in fibroblasts were depleted using S100A4 driven Cre. Similar to enolase 2-Cre, Ang II-induced medial thickening was attenuated in the ascending, but not the descending aorta. Lineage tracking demonstrated an increase of S100A4-LacZ positive cells in the media of the ascending region during Ang II infusion. CONCLUSIONS:AT1a receptor depletion in fibroblasts attenuates Ang II-induced medial hyperplasia in the ascending aorta.
Authors: Brian C Tieu; Xiaoxi Ju; Chang Lee; Hong Sun; Wanda Lejeune; Adrian Recinos; Allan R Brasier; Ronald G Tilton Journal: J Vasc Res Date: 2010-11-23 Impact factor: 1.934
Authors: Eric Lazartigues; Shannon M Dunlay; Angela K Loihl; Puspha Sinnayah; Julie A Lang; Joshua J Espelund; Curt D Sigmund; Robin L Davisson Journal: Circ Res Date: 2002-03-22 Impact factor: 17.367
Authors: Anh T Nguyen; Delphine Gomez; Robert D Bell; Julie H Campbell; Alexander W Clowes; Giulio Gabbiani; Cecilia M Giachelli; Michael S Parmacek; Elaine W Raines; Nancy J Rusch; Mei Y Speer; Michael Sturek; Johan Thyberg; Dwight A Towler; Mary C Weiser-Evans; Chen Yan; Joseph M Miano; Gary K Owens Journal: Circ Res Date: 2012-10-23 Impact factor: 17.367
Authors: Jeffrey A Jones; Christy Beck; John R Barbour; Jouzas A Zavadzkas; Rupak Mukherjee; Francis G Spinale; John S Ikonomidis Journal: Am J Pathol Date: 2009-09-03 Impact factor: 4.307
Authors: Debra L Rateri; Jessica J Moorleghen; Victoria Knight; Anju Balakrishnan; Deborah A Howatt; Lisa A Cassis; Alan Daugherty Journal: PLoS One Date: 2012-12-07 Impact factor: 3.240
Authors: Levi D Maston; David T Jones; Wieslawa Giermakowska; Tamara A Howard; Judy L Cannon; Wei Wang; Yongyi Wei; Weimin Xuan; Thomas C Resta; Laura V Gonzalez Bosc Journal: Am J Physiol Lung Cell Mol Physiol Date: 2017-02-17 Impact factor: 5.464
Authors: Ying H Shen; Scott A LeMaire; Nancy R Webb; Lisa A Cassis; Alan Daugherty; Hong S Lu Journal: Arterioscler Thromb Vasc Biol Date: 2020-02-26 Impact factor: 8.311
Authors: Talha Ijaz; Hong Sun; Irina V Pinchuk; Dianna M Milewicz; Ronald G Tilton; Allan R Brasier Journal: Arterioscler Thromb Vasc Biol Date: 2017-08-17 Impact factor: 8.311
Authors: Steven J Forrester; George W Booz; Curt D Sigmund; Thomas M Coffman; Tatsuo Kawai; Victor Rizzo; Rosario Scalia; Satoru Eguchi Journal: Physiol Rev Date: 2018-07-01 Impact factor: 37.312
Authors: Mark W Majesky; Henrick Horita; Allison Ostriker; Sizhao Lu; Jenna N Regan; Ashim Bagchi; Xiu Rong Dong; Joanna Poczobutt; Raphael A Nemenoff; Mary C M Weiser-Evans Journal: Circ Res Date: 2016-11-09 Impact factor: 17.367